Import of Indian drugs blocked by Pak govt
Pakistan government has blocked a proposal for importing 400 medicines from India following intense lobbying against the move by the local pharmaceutical industry.
The proposal forwarded by Pakistan's commerce ministry was stalled ahead of an expected hike of upto 40 per cent in the prices of life-saving drugs in the country.
Prime Minister Yousuf Raza Gilani has reportedly issued a direction that no drug produced in Pakistan should be imported.
Gilani also sought justification for importing from India 13 vaccines and some oncology drugs that are currently not produced in Pakistan, sources told the Dawn newspaper.
However, the import of these vaccines and oncology products will continue.
Health Secretary Khushnood Lashari will meet Commerce Secretary Asif Shah to ensure that the proposal for importing Indian drugs is closed.
Sources in the commerce ministry had leaked information about the proposal to import Indian drugs to the local pharmaceutical industry, which used its "contacts" to pre-empt the move, the daily said.
Local entrepreneurs contended that the proposed imports would threaten the jobs of over one million people, affect annual exports worth more than 120 million dollars and compromise the availability of medicines during emergencies.
Pakistan's pharmaceutical industry is worth Rs 83 billion and enjoys considerable political clout.
Meanwhile, the health ministry's advisory committee on drug prices has recommended a 10 to 40 per cent increase in prices of various life-saving drugs.
Enter your email to get our daily newsletter in your inbox
- Keeping chip production in-house may be bad for Intel because its manufacturing technology has fallen behind Taiwan Semiconductor Manufacturing Co., which makes chips for many of Intel’s rivals. If the US company can’t catch up, its products will become less competitive, lose sales and market share.
- Iran has been subject to tough US sanctions since 2018, when the administration of then-President Donald Trump unilaterally withdrew from an international deal that restricted the Middle Eastern country’s nuclear activities. Its crude production was below 2 million barrels a day for most of 2020.